Background: Few rigorously designed studies have documented the efficacy of interventions to improve medication adherence among patients prescribed highly active antiretroviral. Data are needed to justify the use of limited resources for these programs.
Methods: A 2-arm, randomized, controlled trial evaluated the efficacy of a community-based, home-visit intervention to improve medication adherence. Participants were 171 HIV-infected adults prescribed a minimum of 3 antiretroviral agents. The majority had a past or current history of substance abuse. Subjects were randomly assigned to receive home visits for 1 year or usual care. Medication adherence was assessed with Medication Event Monitoring stem caps at 3-month intervals from randomization through 3 months after the conclusion of the intervention.
Results: A larger proportion of subjects in the intervention group demonstrated adherence greater than 90% compared with the control group at each time point after baseline. The difference over time was statistically significant (Extended Mantel-Haenszel test: 5.80, P = 0.02). A statistically significant intervention effect on HIV-RNA level or CD4 cell count was not seen, but there was a statistically significant association between greater than 90% adherence and an undetectable HIV-RNA over time (P < 0.03).
Conclusion: Home visits from a nurse and a community worker were associated with medication adherence greater than 90% among a cohort of socially vulnerable people living with HIV/AIDS in northeastern United States.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/01.qai.0000221681.60187.88 | DOI Listing |
Tunis Med
January 2025
Department of Endocrinology and Internal Medicine, Fattouma Bourguiba Hospital, Monastir. Tunisia.
Unlabelled: Introduction-Aim: Type 2 diabetes (T2D) is a major public health problem. To succeed its management and prevent its complications, good therapeutic adherence must be ensured. The objectives of our work were to estimate the prevalence of poor therapeutic adherence in our patients and to identify its associated factors.
View Article and Find Full Text PDFJACC Adv
January 2025
Centre for Heart Lung Innovation, University of British Columbia, Vancouver, Canada.
Background: Rates of premature coronary artery disease (CAD) are stagnant, and the prevalence of cardiovascular risk factors in young and middle-aged adults is increasing. Lipid-lowering therapy (LLT) is effective in preventing CAD but is underutilized in younger patients. The reasons for and consequences of this underutilization are not fully understood.
View Article and Find Full Text PDFOne Health
June 2025
Dahdaleh Institute for Global Health Research, York University, Canada.
Antimicrobial resistance (AMR) represents one of the biggest threats to health globally. The rise of AMR has been largely attributed to the misuse and abuse of antimicrobials in veterinary, human, and agricultural medicine. This study aimed to assess human, livestock, and agricultural health profiles, and practices of One Health and antibiotic use through a situational analysis of an Indigenous village Gurah, in a rural area of Mohali district in Punjab state using a demographic and facility survey.
View Article and Find Full Text PDFJ Exp Pharmacol
January 2025
Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia.
Acne vulgaris is a prevalent dermatological condition characterized by comedones, papules, and pustules, with significant physical and psychological implications. Conventional treatments for this condition, including antibiotics and retinoids, face challenges, such as side effects and antibiotic resistance, necessitating alternative treatments. Recent studies show the potential of probiotics to modulate skin microbiome and alleviate acne symptoms.
View Article and Find Full Text PDFExp Clin Transplant
December 2024
>From The Faculty of Health Sciences, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
Objectives: Adherence of patients to their immunosuppressive treatment protocol after liver transplant is critical for the health and longevity of the transplanted liver. This study aimed to evaluate and determine the factors affecting the adherence of patients to immunosuppressive therapy after liver transplant.
Materials And Methods: We conducted a cross-sectional descriptive study with patients who had undergone liver transplant in a university hospital between June 2021 and June 2022.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!